| Effectiveness, safety and cost analysis of dalbavancin in clinical practice M Arrieta-Loitegui, JM Caro-Teller, S Ortiz-Pérez, F López-Medrano, ... European Journal of Hospital Pharmacy 29 (1), 55-58, 2022 | 25 | 2022 |
| Analysis of immune-mediated reactions in patients with non-small cell lung cancer treated with nivolumab and its association with effectiveness S Cortijo-Cascajares, AC Cercós-Lletí, S Ortiz-Pérez, JM Caro-Teller, ... Journal of Oncology Pharmacy Practice 29 (2), 290-298, 2023 | 3 | 2023 |
| Suministro controlado de tocilizumab durante la pandemia de COVID-19 e influencia sobre el tratamiento de pacientes reumatológicos S Ortiz Pérez, JM Caro Teller, C García Muñoz, P Herraiz Robles, ... Revista Española de Salud Pública 95 (1), e1-e6, 2021 | 3* | 2021 |
| Impacto de un plan de mejora de calidad en la validación de la prescripción de fármacos sobre la seguridad de los pacientes hospitalizados CR Espinoza, JMC Teller, MA Loitegui, AL Cebas, SO Pérez, MJJ Cerezo, ... Journal of Healthcare Quality Research 35 (5), 313-318, 2020 | 1 | 2020 |
| Influence of a pharmaceutical intervention program on the use of potentially inappropriate medications in elderly patients JMC Teller, SO Pérez, MG Sevilla, MJJ Cerezo, CG Gómez, JMF Piquero European journal of clinical pharmacy: atención farmacéutica 20 (4), 197-203, 2018 | 1 | 2018 |
| 4CPS-189 Association between the development of immune-related adverse events and the effectiveness of ipilimumab in advanced melanoma JAH Ramos, SC Cascajares, JMC Teller, MAB Montero, SO Perez, ... European Journal of Hospital Pharmacy 29 (Suppl 1), A91-A91, 2022 | | 2022 |
| Variabilidad en el registro de alergias entre niveles asistenciales S Ortiz Pérez, JM Caro Teller, M González Sevilla, JM Ferrari Piquero Revista de la OFIL 31 (2), 139-142, 2021 | | 2021 |
| 4CPS-028 Experience of ceftaroline use in a third level hospital D Canales, JMC Teller, FM De La Torre, MA Loitegui, C Rosas, SO Pérez, ... European Journal of Hospital Pharmacy 27 (Suppl 1), A60-A60, 2020 | | 2020 |
| 4CPS-026 Dalbavancin off-label use: effectiveness and safety M Arrieta, JM Caro-Teller, S Ortiz-Pérez, C Rosas-Espinoza, ... European Journal of Hospital Pharmacy 27 (Suppl 1), A59-A59, 2020 | | 2020 |
| Pharmaceutical contribution in postoperative bacterial ventriculitis: A case report SO Pérez, JMC Teller, MG Sevilla, CG Muñoz, JMF Piquero European journal of clinical pharmacy: atención farmacéutica 20 (6), 335-336, 2018 | | 2018 |
| PKP-011 Drug interactions and safety profile in patients treated with riociguat MN Sedano, JMC Teller, DF Redondo, SO Perez, JMF Piquero European Journal of Hospital Pharmacy 24 (Suppl 1), A198-A198, 2017 | | 2017 |
| Effectiveness and safety of pirfenidone used for treatment of idiopathic pulmonary fibrosis M Gonzalez Sevilla, C Garcia Munoz, S Ortiz Perez, A Lazaro Cebas, ... INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 39 (1), 327-327, 2017 | | 2017 |
| Effectiveness and safety of ibrutinib used for the treatment of relapsed and refractory mantle-cell lyphoma: experience in a third level hospital A Lazaro Cebas, C Garcia Munoz, S Pablos Bravo, M Gonzalez Sevilla, ... INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 39 (1), 328-328, 2017 | | 2017 |
| Hepatitis c virus relapses in patients treated with second generation direct-acting antivirals D Fernandez-Redondo, O Pinar Lopez, A Lazaro Cebas, S Ortiz Perez, ... INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 39 (1), 326-326, 2017 | | 2017 |
